Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -6.22% | +78.50% |
2019 | Argos Therapeutics, Inc. Went Out of Business | CI |
2019 | First Amended Liquidation Plan Approved for Argos Therapeutics, Inc. | CI |
Financials (USD)
Sales 2016 | 945K | Sales 2017 | 1.9M | Capitalization | 13.18M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -40M | EV / Sales 2016 | 200 x |
Net cash position 2016 | 13.11M | Net Debt 2017 | 4.27M | EV / Sales 2017 | 9.19 x |
P/E ratio 2016 |
-2.96
x | P/E ratio 2017 |
-0.22
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 88.73% |
1st Jan change | Capi. | |
---|---|---|
+78.50% | 567K | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- ARGSQ Stock